Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era?

Authors:
Bayry J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV.

Journal:
Trends Pharmacol Sci

Publication Year: 2004

DOI:
10.1016/j.tips.2004.04.002

PMCID:
PMC7127229

PMID:
15165745

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Trends Pharmacol Sci

Abbreviation: Trends Pharmacol Sci

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Developing novel antifungals: lessons from G protein-coupled receptors.
Velazhahan V; McCann BL; Bignell E and 1 more (2023) - Transparency Score: 3/6
A decoy mutant ACE2 designed to reduce COVID-19.
Maishan M; Lim DL; Zimmerman GA and 1 more (2022) - Transparency Score: 2/6
Lessons from COVID-19 to increase opioid vaccine acceptance.
Damiescu R; Banerjee M; Paul NW and 1 more (2022) - Transparency Score: 2/6
Monkeypox: potential vaccine development strategies.
Lozano JM; Muller S. (2022) - Transparency Score: 3/6
Targeting SARS-CoV-2 papain-like protease in the postvaccine era.
Ton AT; Pandey M; Smith JR and 3 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"Supported by grants from Institut National de la Santé et de la Recherche Médicale (INSERM) and Centre National de la Recherche Scientifique (CNRS), France; ZLB Bioplasma AG, Switzerland and Octapharma, Austria. We are grateful to Jean-Michel Alonso for the conception of Figure 1, and to Sylvia Miescher, Beda Stadler and John Morrow for critical reading of the manuscript. Because of space limitation, we could only cite recent published work, which does not undermine the great value of uncited studies."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025